Tenderwize
Retour à la recherche

Drug Testing Reagents and Analyzer Lease

SZPITAL UNIWERSYTECKI W KRAKOWIE·Kraków, Poland·PLN 1.2M | EUR 282.2k·Expired · Jul 21, 2026·Open·Supplies
Structured notice only
Titre original de l'avis

Poland – Laboratory reagents – DFP.271.115.2026.EP Dostawa odczynników, materiałów zużywalnych, kontrolnych pozwalających na wykonanie badań oraz zwalidowanie i wydanie wyników (CPR) do oznaczania leków w krwi wraz z dzierżawą sprzętu dla Zakładu Diagnostyki.

60/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

40 / 100

Facteurs de risque

Structured data indicates EU funding but XML notice explicitly states no EU funds. This discrepancy could affect contra...

Strict exclusion grounds including Russian entity ban and broad disqualification under Polish law. Any past non-complia...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • PLN 1.2M estimated value
  • Supplies contract
  • 1 lot
  • Duration 12 MONTH
  • Supply of laboratory reagents and consumables for 24 drug analytes (e.g., cyclosporine, tacrolimus, vancomycin) with specified test quantities.
  • Lease of one automatic analyzer including centrifuge and thermostat for the contract duration.
Afficher le résumé complet

The procurement by University Hospital in Krakow (Poland) is for the supply of reagents, consumables, and controls for drug testing in blood, along with the lease of an automatic analyzer for the Diagnostics Department. The contract duration is 12 months with an estimated value of 1,202,777.40 PLN. The procedure is open, award is based solely on cost (100% weight), and electronic submission is required via the platform. There is a conflict between structured data (EU-funded) and the XML notice (no EU funding).

Risques

Structured data indicates EU funding but XML notice explicitly states no EU funds. This discrepancy could affect contra...

Strict exclusion grounds including Russian entity ban and broad disqualification under Polish law. Any past non-complia...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Deliver exact quantities per analyte as listed (e.g., Tacrolimus: 20,000 tests).
  • Provide analyzer lease for 12 months.

Eligibility

  • Comply with exclusion grounds: no conflicts of interest, no criminal/administrative violations, no affiliation with Russian entities per EU sanctions.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Lowest cost (100% weight)100%

Acheteur

Localisation

Kraków, POL

Profil acheteur

Ouvrir le profil

Identifiant

000288685

Activité

Health

Lots (1)

LOT-0001

Drug Testing Reagents and Analyzer Lease

Supply of 24 reagents (e.g., cyclosporine, tacrolimus, digoxine) with specific test quantities and lease of an automatic analyzer with centrifuge and thermostat.

SuppliesEU fundedElectronic submission

EUR 282.2k

Valeur estimée

Localisation

PL213, Poland

Durée

12 MONTH

Catégorie

Laboratory reagents

Critères d'attribution

Cost

Date limite

Expired Jul 21, 2026

Détails de la procédure

Date de publication
21 Jun 2026
Langues
Polish

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
426513-2026

Documents (1)

Appels d'offres similaires